John R. Stuelpnagel, Director at 10x Genomics, Inc. (TXG), sold 5,000 shares at $151.79 ($756K) on 2021-12-01, disclosed to the SEC on 2021-12-03.
Open-market sale of $756k TXG by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $150.51 | 2,000 | $301K | 39.8% |
| 2 | $151.10 | 1,700 | $257K | 34.0% |
| 3 | $151.79 | 1,100 | $167K | 22.1% |
| 4 | $154.02 | 100 | $15K | 2.0% |
| 5 | $155.55 | 100 | $16K | 2.1% |
| Total | $151.16 avg | 5,000 |
| $756K |
| 100% |
| Filing → |
| TXG | SELL | 2023-06-07 | $549K | — | Filing → |
| TXG | SELL | 2022-01-04 | $1.5M | — | Filing → |
| TXG | SELL | 2021-11-18 | $1.6M | — | Filing → |